Jüri Ratas Chemical compound Pharmaceutical compound Metizoline (trade name Ellsyl) is a nasal decongestant against allergic and vasomotor rhinitis.[1] References ^ Zumpft CW (January 1975). "Double-blind comparison of metizoline hydrochloride (Ellsyl) and phenylephrine in allergic and vasomotor rhinitis". Current Therapeutic Research, Clinical and Experimental. 17 (1): 40–6. PMID 49255. Decongestants and other nasal preparations (R01)TopicalSympathomimetics, plain Amidephrine Cyclopentamine Ephedrine Epinephrine Fenoxazoline Iproheptine Levmetamfetamine Methylephedrine Metizoline Naphazoline Oxymetazoline Phenylephrine Propylhexedrine Tetryzoline Tramazoline Tuaminoheptane Tymazoline Xylometazoline Antiallergic agents,excluding corticosteroids Spaglumic acid histamine antagonists (Levocabastine Antazoline Thonzylamine) mast cell stabilizer (some are also antihistamines) (Cromoglicic acid Nedocromil Azelastine Olopatadine Lodoxamide) Corticosteroids Beclometasone dipropionate Betamethasone# Budesonide Ciclesonide Dexamethasone Flunisolide Fluticasone (Fluticasone furoate, Fluticasone propionate) Mometasone furoate Prednisolone# Tixocortol Triamcinolone Triamcinolone acetonide Other nasal preparations Cafaminol Calcium hexamine thiocyanate Eucalyptus oil Framycetin Hexamidine Hyaluronan Ipratropium bromide Mupirocin Retinol Ritiometan Saline water Combination products Olopatadine/mometasone Systemic use:Sympathomimetics Ephedrine Phenylephrine Phenylpropanolamine Pseudoephedrine (+azatadine, +carbinoxamine, +cetirizine, +dexbrompheniramine, +fexofenadine, +loratadine, +naproxen) #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III No tags for this post. Navigeerimine Mihhail VellerKaja Kallas
You must be logged in to post a comment.